We are live on
!
Find out more
EC
Engaged Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
2.09%
This Fund
S&P 500
This Quarter
Est. Return
+31.89%
1 Year Est. Return
-2.09%
3 Year Est. Return
+16.33%
5 Year Est. Return
+36.28%
10 Year Est. Return
+434.46%
AUM
$712M
AUM Growth
+$173M
(+32%)
Cap. Flow
+$27.9M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
98.58%
Holding
16
New
1
Increased
2
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hain Celestial
HAIN
|
+$98.3M |
| 2 |
STKL
SunOpta
STKL
|
+$7.26M |
| 3 |
Medifast
MED
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Benchmark Electronics
BHE
|
+$48.5M |
| 2 |
Anika Therapeutics
ANIK
|
+$12.6M |
| 3 |
Groupon
GRPN
|
+$7.83M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$4.64M |
| 5 |
Astec Industries
ASTE
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 58.96% |
| 2 | Technology | 21.01% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 2.11% |
| 5 | Consumer Discretionary | 0.2% |
Similar funds
ECAM
TC
BPH
BCC
BKA
SF
AFO
LKBC
Engaged Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Engaged Capital held 16 positions worth $712M, up 32% from $539M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Engaged Capital deployed $27.9M of net new capital in Q1 2019, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Medifast: 11,242 shares worth $1.43M.
By sector, the portfolio is most concentrated in Consumer Staples at 59% of assets, up from 40% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Benchmark Electronics, an estimated $48.5M trimmed.
- Engaged Capital's largest Q1 2019 buy was Medifast: 11,242 shares worth $1.43M.
- Engaged Capital added most to Hain Celestial in Q1 2019, an estimated $98.3M increase.
- Engaged Capital's biggest Q1 2019 reduction was Benchmark Electronics, cutting an estimated $48.5M.
- Engaged Capital fully exited Anika Therapeutics in Q1 2019, selling an estimated $12.6M.
- Engaged Capital's ten largest holdings make up 99% of its $712M portfolio in Q1 2019.
- Engaged Capital opened 1 new position and closed 4 in Q1 2019.
- Engaged Capital's portfolio value rose 32% quarter-over-quarter to $712M.
Based on Engaged Capital's 13F filing for Q1 2019, filed 15 May 2019.